Transmucosal oxygen tension of the clitoris: a new parameter for future investigations of the sexual, metabolic, and cardiovascular health of women
Several studies suggested that abnormalities in tissue perfusion of external genitalia and vagina can lead to female sexual dysfunctions (FSDs) and can be associated to metabolic and cardiovascular risk factors. However, there are some technical difficulties in assessing these abnormalities. The measurement of oxygen partial pressure is a noninvasive method to measure oxygen partial pressure (pO2) at the skin surface to assess tissue perfusion. The aim of this study was to evaluate whether transmucosal oxygen tension (TmPO2) can be measured at the mucosal surface of clitoris and whether the measurements are reliable.
TmPO2 was measured in six young healthy women by using a device to measure transcutaneous pO2 on the skin and by choosing a small sensor, usually used for newborns. The identical procedure for the detection of pO2 at the skin surface was used.
The mean value of TmPO2 was 42.3 mmHg (range: 24.1–53.4 mmHg). All the trend curves of the TmPO2 showed the same behavior: after a stabilization time, there was a stable pO2 (plateau phase) that corresponds to the TmPO2 of the clitoris. These curves had a similar trend to those recorded at the skin surface.
TmPO2 can be easily measured at the mucosal surface of clitoris. Large epidemiological studies in healthy and unhealthy women and in women with FSD are needed to establish both the normal range of TmPO2 and the meaning that different values of TmPO2 can have on sexual and general health of the women.
KeywordsFemale sexuality Oxygen tension Cardiovascular risk Clitoris Tissue perfusion
This study was funded by Istituto Clinico Beato Matteo, Vigevano (current research)
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The informed consent was obtained from all the subjects recruited in the study.
Informed consent was obtained by all the subjects recruited in the study.
- 1.M.I. Maiorino, G. Bellastella, K. Esposito, Diabetes and sexual dysfunction: current perspectives. Diabetes Metab. Syndr. Obes. 7, 95–105 (2014)Google Scholar
- 2.I. Goldstein, J.R. Berman, Vasculogenic female sexual dysfunction: vaginal engorgement and clitoral erectile insufficiency syndromes. Int. J. Impot. Res. 10, S84–S89 (1998)Google Scholar
- 3.M.I. Maiorino, G. Bellastella, D. Giugliano, K. Esposito, From inflammation to sexual dysfunctions: a journey through diabetes, obesity, and metabolic syndrome. J. Endocrinol. Invest. https://doi.org/10.1007/s40618-018-0872-6 (2018)
- 10.C. Gazzaruso, S.B. Solerte, A. Pujia, A. Coppola, M. Vezzoli, F. Salvucci, C. Valenti, A. Giustina, Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: A potential protective role for statins and 5-phosphodiesterase inhibitors. J. Am. Coll. Cardiol. 51(21), 2040–2044 (2008).CrossRefGoogle Scholar
- 11.C. Gazzaruso, A. Coppola, T. Montalcini, C. Valenti, A. Garzaniti, G. Pelissero, F. Salvucci, P. Gallotti, A. Pujia, C. Falcone, S.B. Solerte, A. Giustina, Erectile dysfunction can improve the effectiveness of the current guidelines for the screening for asymptomatic coronary artery disease in diabetes. Endocrine 40(2), 273–279 (2011).CrossRefGoogle Scholar
- 12.C. Gazzaruso, A. Coppola, A. Pujia, C. Falcone, S. Collaviti, M. Fodaro, P. Gallotti, S.B. Solerte, A. Giustina, G. Pelissero, L. Luzi, T. Montalcini, Erectile dysfunction as a predictor of asymptomatic coronary artery disease in elderly men with type 2 diabetes. J. Geriatr. Cardiol. 13(6), 552–556 (2016)Google Scholar
- 13.C. Battaglia, E. Morotti, N. Persico, B. Battaglia, P. Busacchi, P. Casadio, R. Paradisi, S. Venturoli, Clitoral vascularization and sexual behavior in young patients treated with drospirenone-ethinyl estradiol or contraceptive vaginal ring: a prospective, randomized, pilot study. J. Sex. Med. 11(2), 471–480 (2014)CrossRefGoogle Scholar
- 18.C. Gazzaruso, A. Coppola, T. Montalcini, E. Baffero, A. Garzaniti, G. Pelissero, S. Collaviti, A. Grugnetti, P. Gallotti, A. Pujia, S.B. Solerte, A. Giustina, Lipoprotein(a) and homocysteine as genetic risk factors for vascular and neuropathic diabetic foot in type 2 diabetes mellitus. Endocrine 41(1), 89–95 (2012)CrossRefGoogle Scholar
- 19.C. Gazzaruso, A. Coppola, C. Falcone, C. Luppi, T. Montalcini, E. Baffero, P. Gallotti, A. Pujia, S.B. Solerte, G. Pelissero, A. Giustina, Transcutaneous oxygen tension as a potential predictor of cardiovascular events in type 2 diabetes: comparison with ankle–brachial index. Diabetes Care 36(6), 1720–1725 (2013)CrossRefGoogle Scholar
- 23.C. Gazzaruso, A. Coppola, T. Montalcini, C. Valenti, G. Pelissero, S.B. Solerte, F. Salvucci, P. Gallotti, A. Pujia, A. Garzaniti, A. Giustina, Screening for asymptomatic coronary artery disease can reduce cardiovascular mortality and morbidity in type 2 diabetic patients. Intern. Emerg. Med. 7(3), 257–266 (2012)CrossRefGoogle Scholar